Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie A Lemm

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|October 1, 2014
Potency and resistance analysis of hepatitis C virus NS5B polymerase inhibitor BMS-791325 on all major genotypesMengping Liu, Maria Tuttle, Min Gao, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2012
Effect on hepatitis C virus replication of combinations of direct-acting antivirals, including NS5A inhibitor daclatasvirLenore A Pelosi, Stacey Voss, Mengping Liu, et al.
Journal of Virology|May 28, 2003
Specific inhibition of bovine viral diarrhea virus replicaseJin-Hua Sun, Julie A Lemm, Donald R O'Boyle, et al.
Intervirology|April 7, 2005
Replication-competent chimeric hepatitis C virus subgenomic repliconsJulie A Lemm, Mengping Liu, Ronald E Rose, et al.
Antimicrobial Agents and Chemotherapy|January 1, 2013
Combinations of lambda interferon with direct-acting antiviral agents are highly efficient in suppressing hepatitis C virus replicationJacques Friborg, Steven Levine, Chaoqun Chen, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2005
Development of a cell-based high-throughput specificity screen using a hepatitis C virus-bovine viral diarrhea virus dual replicon assayDonald R O'Boyle, Peter T Nower, Julie A Lemm, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2014
Identification of a novel series of potent HCV NS5B Site I inhibitorsKyle J Eastman, Zhong Yang, John A Bender, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2016
Discovery and preclinical evaluation of potent, orally bioavailable, metabolically stable cyclopropylindolobenzazepine acylsulfonamides as thumb site 1 inhibitors of the hepatitis c virus NS5B RNA-dependent, RNA polymerasePiyasena Hewawasam, Yong Tu, Min Gao, et al.
Journal of Medicinal Chemistry|March 14, 2014
Discovery and development of hepatitis C virus NS5A replication complex inhibitorsMakonen Belema, Omar D Lopez, John A Bender, et al.
Journal of Virology|October 9, 2009
Identification of hepatitis C virus NS5A inhibitorsJulie A Lemm, Donald O'Boyle, Mengping Liu, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|October 1, 2014
Potency and resistance analysis of hepatitis C virus NS5B polymerase inhibitor BMS-791325 on all major genotypesMengping Liu, Maria Tuttle, Min Gao, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2012
Effect on hepatitis C virus replication of combinations of direct-acting antivirals, including NS5A inhibitor daclatasvirLenore A Pelosi, Stacey Voss, Mengping Liu, et al.
Journal of Virology|May 28, 2003
Specific inhibition of bovine viral diarrhea virus replicaseJin-Hua Sun, Julie A Lemm, Donald R O'Boyle, et al.
Intervirology|April 7, 2005
Replication-competent chimeric hepatitis C virus subgenomic repliconsJulie A Lemm, Mengping Liu, Ronald E Rose, et al.
Antimicrobial Agents and Chemotherapy|January 1, 2013
Combinations of lambda interferon with direct-acting antiviral agents are highly efficient in suppressing hepatitis C virus replicationJacques Friborg, Steven Levine, Chaoqun Chen, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2005
Development of a cell-based high-throughput specificity screen using a hepatitis C virus-bovine viral diarrhea virus dual replicon assayDonald R O'Boyle, Peter T Nower, Julie A Lemm, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2014
Identification of a novel series of potent HCV NS5B Site I inhibitorsKyle J Eastman, Zhong Yang, John A Bender, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2016
Discovery and preclinical evaluation of potent, orally bioavailable, metabolically stable cyclopropylindolobenzazepine acylsulfonamides as thumb site 1 inhibitors of the hepatitis c virus NS5B RNA-dependent, RNA polymerasePiyasena Hewawasam, Yong Tu, Min Gao, et al.
Journal of Medicinal Chemistry|March 14, 2014
Discovery and development of hepatitis C virus NS5A replication complex inhibitorsMakonen Belema, Omar D Lopez, John A Bender, et al.
Journal of Virology|October 9, 2009
Identification of hepatitis C virus NS5A inhibitorsJulie A Lemm, Donald O'Boyle, Mengping Liu, et al.
Pageof 3